Jonathan Young Akero Therapeutics, Inc. (AKRO) insider trading activity

Jonathan Young is Chief Operating Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 196,594 shares of AKRO, which is worth approximately $11 Million. The most recent transaction as insider was on May 03, 2021, when has been sold 3,055 shares (Common Stock) at a price of $30.56 per share, resulting in proceeds of $93,361. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 197K

1.97% 3M change

20.36% 12M change

Total Value Held $11 Million

Jonathan Young Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 03 2021	SELL Open market or private sale	$93,361 $30.56 p/Share	3,055 Reduced 1.8%	167,065 Common Stock
Apr 01 2021	SELL Open market or private sale	$87,831 $28.75 p/Share	3,055 Reduced 1.76%	170,120 Common Stock
Mar 01 2021	SELL Open market or private sale	$94,094 $30.8 p/Share	3,055 Reduced 1.73%	173,175 Common Stock
Feb 01 2021	SELL Open market or private sale	$90,306 $29.56 p/Share	3,055 Reduced 1.7%	176,230 Common Stock
Jan 08 2021	SELL Open market or private sale	$281,200 $28.12 p/Share	10,000 Reduced 5.28%	179,285 Common Stock
Jan 07 2021	BUY Exercise of conversion of derivative security	$4,650 $0.62 p/Share	7,500 Added 3.81%	189,285 Common Stock
Jan 04 2021	SELL Open market or private sale	$78,458 $25.64 p/Share	3,060 Reduced 1.66%	181,785 Common Stock
Jun 30 2020	BUY Grant, award, or other acquisition	$21,252 $17.07 p/Share	1,245 Added 0.67%	184,845 Common Stock

Jonathan Young

Chief Operating Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKRO shares.

Notify only if

Value

Insider Trading

Get notified when an Akero Therapeutics, Inc. insider buys or sells AKRO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Akero Therapeutics, Inc.

Track Activities on AKRO

Account